Results of Omkar Speciality Chemicals Ltd for Q4 & FY15

Omkar Speciality Chemicals Limited Consolidated Results. FY15 PAT up by 79.06 % at Rs. 24.28 crore Total Income up by 10.34 % at Rs. 265.13 core
By: Omkar Speciality Chemicals Limited
 
MUMBAI, India - May 20, 2015 - PRLog -- Mumbai, May 19, 2015: Omkar Speciality Chemicals Ltd (OSCL), a leading company in the field of Speciality Chemicals and Active Pharmaceutical Ingredients (APIs), today declared its financial results for the fourth quarter and full year ended March 31, 2015.

The company reported a healthy increase of 63.25% in its Net Profit to Rs. 5.42 crore for Q4FY15, as compared to Rs. 3.32 crore in the corresponding quarter of last fiscal. The company’s PAT margin improved from 4.49% in Q4FY14 to 7.34% in Q4FY15.

Total Income for the quarter ended March 31, 2015 stood at Rs. 73.89 crore, as compared to Rs. 73.94 crore in the same period last year.

OSCL’s Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q4FY15 stood at Rs. 14.04 crore, up 21.45%. The company’s EBITDA margin improved from 15.63% in Q4FY14 to 19.00% in Q4FY15.

For the full year period ended March 31, 2015, OSCL’s net profit jumped by 79.06% to Rs. 24.28 crore, as compared to Rs. 13.56 crore of the year ago period. The company’s PAT margin improved from 5.64% in FY14 to 9.16% in FY15.

Total income for FY15 stood at Rs. 265.13 crore, recording a rise of 10.34% as compared to Rs. 240.28 crore during FY14.  OSCL’s EBITDA in FY15 stood at Rs. 52.17 crore, up 21.50%. The company’s EBITDA margin improved from 17.87% in FY14 to 19.68% in FY15.

Commenting on the financial performance of the company Mr. Omkar Herlekar, the Whole Time Director, Omkar Speciality Chemicals Ltd, said, “The margins have improved considerably as the company is focusing more on speciality chemicals and APIs as compared to commodity chemicals. The margins enjoyed in the former two segments are significantly higher.  In the forthcoming fiscal year, the margins are likely to improve further because of higher composition of speciality chemicals and APIs in the total sales.”

Earnings per share (EPS) for the quarter ended Q4FY15 stood at Rs. 2.64, up 63.98% as compared with Rs. 1.61 for the quarter ended March 31, 2014. For FY15, EPS stood at Rs. 12.03, up 88.26%, as against Rs. 6.39 in FY14.

The Board of Directors has recommended a dividend of 15% per equity share of Rs. 10 each for FY15.

About Omkar Speciality Chemicals Limited (www.omkarchemicals.com; BSE- 533317; NSE- OMKARCHEM)

A leading speciality chemicals company, OSCL’s core business is manufacturing of niche lifesaving intermediates, Active Pharmaceuticals Ingredients (APIs) and Veterinary Growth enhancers. Headquartered at Thane, OSCL has nine units in the state of Maharashtra, India with over 1,100 workforce. The company is fully backward integrated and has an installed capacity of 4,920 MTPA. The Company’s product segments include Iodine Compounds, Selenium Compounds, Intermediates, Resolving Agents, Veterinary Growth Enhancers and APIs which comprises of more than 200 products. The Inorganic Intermediates include Selenium derivatives and Iodine derivatives. These products find applications in various industries like Pharmaceutical Industry, Chemical Industry, Glass Industry, Cosmetics, Ceramic Pigments and Cattle & Poultry Feeds. The company’s association with leading organizations in India and abroad has enabled it to broaden its business, to expand the existing product range and to develop new molecules as per the specific requirements of customers. The company is certified with ISO 9001:2008 and FAMI-QS & GMP
End
Source:Omkar Speciality Chemicals Limited
Email:***@gmail.com
Tags:Omkar, Speciality, Chemical, Performance, Result
Industry:Industrial
Location:Mumbai - Maharashtra - India
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Concept PR PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share